Wim Plast

Sector: Manufacturing (Plastic Injection Moulding Unit)  |  HQ: India  |  Founded: Not separately disclosed  |  Employees: Not separately disclosed

Listed as: Privately held  | 

Company overview

Wim Plast operates in the manufacturing segment of the Indian market, with a presence noted in the plastic injection moulding unit category. The company is among the recognised participants in this segment alongside other Indian and multinational players. Operations follow the standard Companies Act 2013 disclosure framework where Wim Plast is incorporated as a private or public limited company under Indian law, with statutory audit, GST registration under the CGST Act 2017, and applicable sectoral compliance under FSSAI, BIS, MoEF, or sectoral regulators as relevant to the activity. The competitive set in plastic injection moulding unit includes pan-India brands, regional players, and multinational subsidiaries operating in India through wholly-owned or joint-venture structures.

Recent developments

May 2026

Wim Plast is undergoing a significant corporate restructuring, with the NCLT Ahmedabad sanctioning a composite scheme of arrangement involving Cello Consumer Products and Cello World [1]. Alongside this, the company opened a special window for physical share transfer and dematerialisation in March 2026, indicating active capital restructuring activity [5]. Notable investor interest has emerged, with Ramesh Damani acquiring a stake in the company in January 2026, driving the stock up 19% [3][4]. Ashish Kacholia also entered a position around the same period, with both investors targeting microcap opportunities [2][6]. Meanwhile, the stock has faced pressure, falling to a 52-week low of Rs.350 in March 2026 amidst a continued downtrend [8].

The convergence of high-profile investor backing and the NCLT-approved restructuring scheme signals a pivotal phase for Wim Plast. The involvement of prominent investors like Damani and Kacholia, known for value-oriented microcap plays, alongside the pending scheme with Cello entities, could reshape the company's strategic direction. However, the sustained stock decline to 52-week lows suggests market concerns about the company's near-term fundamentals remain elevated.

Sources (7)

1. NCLT Ahmedabad Sanctions Composite Scheme of Arrangement Among Wim Plast, Cello Consumer Products, and Cello World - scanx.trade · scanx.trade · Tue, 19 May 2026
2. Super Investors Eye Microcaps: Damani Buys Wim Plast, Kacholia Bets on Techera - Whalesbook · Whalesbook · Fri, 23 Jan 2026
3. Ramesh Damani buys stake in this plastic products firm, stock up 19% - Business Today · Business Today · Tue, 20 Jan 2026
4. Investor Ramesh Damani Acquires Stake in this Smallcap Stock. Here's Why... - Equitymaster · Equitymaster · Tue, 20 Jan 2026
5. Wim Plast Limited Opens Special Window for Physical Share Transfer and Dematerialisation - scanx.trade · scanx.trade · Sat, 14 Mar 2026
6. Ramesh Damani & Ashish Kacholia’s latest microcap bets: Value meets defence - financialexpress.com · financialexpress.com · Fri, 23 Jan 2026
7. Wim Plast Ltd. Stock Falls to 52-Week Low of Rs.350 Amidst Continued Downtrend - Markets Mojo · Markets Mojo · Mon, 09 Mar 2026

Financial performance and recent trajectory

Disclosed revenue (FY25): Not separately disclosed in segment-wise FY 2024-25 reporting.

Competitive position

Wim Plast occupies a position in the plastic injection moulding unit category alongside other listed and unlisted Indian players. Competitive intensity in the segment is shaped by raw material cost cycles, distribution depth, branded versus unbranded share, and the regulatory framework governing manufacturing, FSSAI labelling (for food), BIS standards (for engineering goods), or sectoral norms. The principal competitive moats in this category are typically scale, distribution reach, brand trust, and integrated procurement. KAMRIT's project report on plastic injection moulding unit benchmarks new entrant economics against the listed peer cost structure including capex per tonne (or per unit of output), working capital intensity, gross margin band, and the EBITDA delta between organised and unorganised participants.

Key risks

Input cost volatility in the plastic injection moulding unit value chain Competitive intensity from larger Indian groups and multinational subsidiaries Regulatory tightening under FSSAI, BIS, environmental norms, or labour codes

Outlook

Wim Plast is a participant in the Indian plastic injection moulding unit category, which forms part of the broader Manufacturing space. The Indian plastic injection moulding unit market continues to evolve with rising organised share, premiumisation, distribution expansion, and a regulatory architecture covering the Companies Act 2013, the Income Tax Act 1961, the CGST Act 2017, the Legal Metrology Act 2009, and sectoral statutes including the Food Safety and Standards Act 2006 (for food and beverage subsegments), the Drugs and Cosmetics Act 1940 (for pharmaceutical or healthcare adjacencies), the Environment Protection Act 1986 (for emissions and effluents), and labour codes consolidated under the four 2020 labour codes. In KAMRIT's project report framework for this category, the competitive set typically includes pan-India branded leaders, multinational subsidiaries, mid-sized regional players, and a long tail of MSME participants. The structural attractiveness of the category for new entrants is a function of (a) market growth rate, (b) the share that remains with unorganised or fragmented operators, (c) the cost of regulatory compliance, and (d) the capex intensity of plant and machinery. The KAMRIT bankable DPR for this category structures a new entrant's economics against this competitive landscape. For Wim Plast specifically, public-domain disclosures provide a baseline view of operations, but segment-wise revenue, EBITDA, capacity utilisation, and forward capex plans are not separately broken out in many cases. Where the company is part of a listed group, the SEBI LODR and the Companies Act 2013 governance framework apply, with statutory audit conducted under SA 700 and CARO 2020 reporting. Where the company is unlisted, the Companies Act 2013 framework continues to govern with reduced public disclosure. The risk and opportunity outlook for Wim Plast mirrors the broader plastic injection moulding unit category dynamics. Demand-side drivers include rising household consumption, urbanisation, organised retail expansion, and policy support including PLI schemes (where applicable to the segment). Supply-side risks include input cost volatility, regulatory tightening, environmental compliance escalation, and competitive intensity from larger groups or imports. Management quality, balance sheet strength, distribution depth, and the capex execution track record are the differentiators within the peer set. KAMRIT's research desk maintains a baseline reference for Wim Plast as a peer benchmark within the plastic injection moulding unit category. For investors, lenders, or new entrant promoters seeking a fuller assessment of Wim Plast, KAMRIT's deep-dive company profile engagement covers financial trajectory, capacity and capex, distribution and customer concentration, regulatory exposure, and the competitive position with named peers.

KAMRIT point of view

Building or competing with Wim?

KAMRIT advises promoters, family offices, and global enterprises evaluating greenfield entry into the manufacturing (plastic injection moulding unit) sector. Our Bankable DPR with Cost Model and ROI benchmarks your project economics against the listed-company cost structure of Wim and peers. The Execution Partnership tier covers everything from incorporation through commissioning. A 20-minute scoping call with our partners is free.

View all 1 related project report → Book a scoping call

Related KAMRIT project reports

These reports use Wim Plast in benchmarking and competitive analysis sections.

Disclaimer: This profile is compiled by KAMRIT Financial Services LLP for educational and benchmarking purposes only. It is not investment advice, a recommendation to buy or sell securities, or a solicitation. Stock data is provided by Yahoo Finance and may be delayed by up to 20 minutes. Company financial commentary draws on publicly available filings, exchange disclosures, and KAMRIT industry research. Readers should consult a SEBI-registered investment adviser before making investment decisions. KAMRIT is a financial services and compliance firm, not a SEBI-registered investment adviser.